A detailed history of New Edge Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, New Edge Wealth, LLC holds 41,412 shares of NVO stock, worth $5.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
41,412
Previous 29,129 42.17%
Holding current value
$5.9 Million
Previous $3.01 Million 76.47%
% of portfolio
0.12%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $1.25 Million - $1.67 Million
12,283 Added 42.17%
41,412 $5.32 Million
Q4 2023

Jan 29, 2024

SELL
$87.78 - $105.45 $84,444 - $101,442
-962 Reduced 3.2%
29,129 $3.01 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $1.39 Million - $3.05 Million
15,303 Added 103.48%
30,091 $2.74 Million
Q2 2023

Aug 09, 2023

BUY
$155.98 - $172.65 $4,679 - $5,179
30 Added 0.2%
14,788 $2.39 Million
Q1 2023

May 08, 2023

SELL
$132.34 - $159.14 $250,784 - $301,570
-1,895 Reduced 11.38%
14,758 $2.35 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $26,355 - $34,779
-257 Reduced 1.52%
16,653 $2.25 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $52,213 - $64,077
-548 Reduced 3.14%
16,910 $1.69 Million
Q2 2022

Aug 09, 2022

BUY
$103.24 - $121.81 $1.41 Million - $1.66 Million
13,666 Added 360.39%
17,458 $1.95 Million
Q1 2022

May 10, 2022

SELL
$93.1 - $112.54 $112,092 - $135,498
-1,204 Reduced 24.1%
3,792 $421,000
Q4 2021

Jan 31, 2022

SELL
$95.88 - $117.08 $14,957 - $18,264
-156 Reduced 3.03%
4,996 $559,000
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $57,405 - $72,501
680 Added 15.21%
5,152 $495,000
Q2 2021

Aug 11, 2021

BUY
$67.66 - $84.76 $43,370 - $54,331
641 Added 16.73%
4,472 $375,000
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $256,906 - $290,466
3,831 New
3,831 $258,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track New Edge Wealth, LLC Portfolio

Follow New Edge Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.